Download (Maharashtra University of Health Sciences) A Bachelor of Medicine, Bachelor of Surgery (MBBS) 1st Year (First Year) 01113A MUHS MBBS Biochemistry Paper I 2023 Winter || MUHS MBBS first year important questions-previous question papers
[
Total N
. o of P:ages 2
01113A
FirstM
. .B.B.S(2)019E,xaminatio(n
Phase-I) Winter-2023
BIOCHEMISTRY
- I
TotalDuration:SectionA+B=3Hours
Section BM
: arks 80
SECTION-B
In
s
: struction1) Useblackbalpoinpteno.nly
2
) Donotwrite
anythin
o g
ntheblankportion
ofthequestio.n
paper
If writ en
a
, nything
suchtypeofactwilbeconsidered
asanat empt
to resort ounfairm
. eans
3
) Al questions
arec.ompulsory
4
) Thenumbertotherightindicates
ful m
. arks
5
)
Drawdiagramswherevern.ecessary
Distributionfsyl abuisnQuestion
Papeirsonlymeantocover
theentiresyl abuswithinthestipulatedfr.ame Theformatisa mere
g
. uidelineQuestionfs
romthesyl abuscanbeaskedinanyp.aper
S
s tudenctanotclaim
thatheQuestiosn
outofs,yl abus
a this
formatanddistribution
hasbeengivenonlyforthesakeof
p
. lacement
7
)
Useacommonanswerbookfors.ections
2
. BriefAnswerQuestion(s
Solveany10Outof1)1 :-
[
1
] 0
?
2
=
a
) Eenumeratanyfourtypesofvaccines
withone xampl.e
each
b
) Whatisle
? ptinMentiointsroleinregulation
ofa.ppetite
c
) Statehowtheglucokinasaendph
e osphofructokinra
e s
actions
are
bypassedin g.luconeogenesis
d
) W
h itre
ctspetooexidativ
ph
o o
n sphoryla
extplain
whytheP:O ratiof r
NA
H DandF2ADHis2.5and1.5r.espectively
e
) D
n efietisaslenfat yascidandgive
twoes.xample
State
hecomposition
of(i) ga
d n
esgliosi() SlowR
g eactin
S
eubstanocfAnaphyla(-x
S
A
). is
RS
f
) N
e amthedvefectiprotein
a dstateheclinicafleature
o s
fOsteogenesi
Im
. perfecta
g
) D
e efinthetermis
. oenzyme
Explatin
heriseandfalpat ern
ofCreatine
K
-
2inase isoenzymeinmyocardialin
. farction
[?
1 +
]
h
) N
e amtheco
er n
s tainusefdordgiscardtin
hefol owing
biomedi.c
w alste
(
i
) co
n t osw
s abco
e n
d taminat
withblood(i) Human
bodyparts
(
i
)i Usedneedles
(
iv
) Syringeswithoutn.eedles
i
)
Drawaneatlabelediagramofthecel m
. embrane
N - 38
P
. .T.O
01113A
J
) Setathebcio
almedicimp
e ortan
of(i) H
c yaluro
a n
cid
(
) Liver
glycogen
(
il
) hneparasulpha(ite
v
) D
. igitalis
k
) N
e amthebilesalts
andstateheirroleinlipid.igestion
3
. ShortArnsweQ
s uestio(n
Solveany8Outof9) :-
1
] 8
?
5
=
40
a
) M
o e
n ntiwoco
n n
s ditio
each
ca
g usin
positiv
a e
ndnegatinvterogen
b
e
. alancEnxplatihevariouis
ndicatorfs
protei.n
quality [2+3]
b
) D
s is
s cutheva
s riou
b
sarrietr
oef ecti-v
d
poc
atito
e rnt co
n
. mmunicatio
c
) Etnlisthepa
er rsameidtncludie
nserulm
ipidprofiltestalong
with eir
normalr.ange
d
) Eix
n plathelipidptieoro
n xida
chairne
n actio
andtherole
ofantioxidant
vi
n ta
s minbgreakint
.
e
) Writeanoteontumorm
. arkers
1
)
A55yreaoldmale
visitetd
hemedicin
OPD
withcomplaoifntcrease
infrnecqyueofun.rinatio
R
s esulotfests
p
derform
a e
rasfo
. l ows
R
o an
m dpla
m s
a gslu
e co=250m
/
d
, g
L G
d lycaithe
n moglo
=8b.5
%,
Urinesugarp.ositive
(
i
) Stateheprobabl.e
diagnosis
(
i
) M
o e
n ntihecr
a iterfiorthedsiagnosftihed.isease [?]
(
ti
) W
t haisgdlycate
h
n
. emoglob
Stiatiesim
. portance [1?|
(
iv
) Enxplaithecause
ofperesenocfsugairnu.rine
1
] 2
[
1
]
g
) E
s n
t lith
e va
u r
s iore
n a
s ctio
ofxtiecnob.iso
me
mtabol
Eixplatihne
phase
I r.eactions
h
)
Statehefu
s nction
ofps.hospholipid
i
)
D
wraanaetla
e b
d eldia
m gra
ofthem
d irto
a c
l hon
e
nlectro
ransp
c o
h rain
alsoshowing
theinhibitors
atvarious
. ites
4
. LongArnsweQ
s uestion
(
Solveany2Outof3) :-
[
2
] x
=
2 1
0 0
a
)
D
i e
b s
e crthepa
aythwofgl.lyyscio
s geno
Expla
h iowitisre
d
. gulate
W
teriano
e tonVoG
e ierk
d
sis
e ea
(
TypIegl
e y
n cog
st
e orad)gi
. sease
[
5
+
3
2
|
b
) D
i e
b s
e crthepaaythwofbeta
oxi
n datiofPcalm.it
a ic dExpla
t ihne
e
i n
c e
s rgetofthepy.athwa
Write
anoteonRefsu.m
disease
c
) Eaxip
n lth
e dnift ere
ty
s peofenzyim
nhibitio
withes.xample
+
+
N - 38
-
2
This post was last modified on 19 November 2023